Stock price history for AbbVie (ABBV)

Highest end of day price: NZ$405.52 NZD on 2025-10-01

Lowest end of day price: NZ$33.53 NZD on 2013-01-08

Stock price history of AbbVie from 2013 to 2026

Annual Stock Price Performance

Year	Performance
2026	-2.21%
2025	30.84%
2024	15.25%
2023	-0.71%
2022	23.99%
2021	34.61%
2020	26.28%
2019	4.83%
2018	-2.67%
2017	60.61%
2016	12.90%
2015	-7.14%
2014	29.96%
2013	56.38%

Stock price for similar companies or competitors

Company	Stock price	Change 1d%	Country
Pfizer PFE	NZ$45.17	2.76%	🇺🇸 USA
Eli Lilly LLY	NZ$1,756	3.66%	🇺🇸 USA
Amgen AMGN	NZ$637.74	4.49%	🇺🇸 USA
Biogen BIIB	NZ$333.84	8.53%	🇺🇸 USA
Gilead Sciences GILD	NZ$253.06	2.10%	🇺🇸 USA
Bristol-Myers Squibb BMY	NZ$102.87	4.15%	🇺🇸 USA
AstraZeneca AZN	NZ$320.31	3.14%	🇬🇧 UK
GSK plc GSK	NZ$99.95	1.79%	🇬🇧 UK
Neurocrine Biosciences NBIX	NZ$234.31	2.37%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions